Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

SpainBack to Spain

Clinical trials in Cordoba – page 12

572 clinical trials in Cordoba, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Cordoba at a glance
572
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

572 trials in Cordoba

Open in trial search

Appendicectomy+1

Recruiting

Study on Reducing Hospital Stay in Children with Complicated Appendicitis Using Amoxicillin and Clavulanic Acid

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Amoxicillin
  • Sponsor:Fundacio Institut De Recerca De L Hospital De La Santa Creu I Sant Pau

Dry age-related macular degeneration+1

Recruiting

Study of Pozelimab and Cemdisiran for Adults with Geographic Atrophy from Age-Related Macular Degeneration

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cemdisiran
  • Sponsor:Regeneron Pharmaceuticals Inc.

Crohn's disease

Recruiting

Study on the Effectiveness and Safety of Obefazimod for Patients with Moderate to Severe Crohn's Disease After Inadequate Response to Other Treatments

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Obefazimod
  • Sponsor:Abivax

Hepatocellular carcinoma+1

Recruiting

Study of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma

Registered drugNo placebo
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:The University Of Birmingham

Glucose tolerance impaired+1

Recruiting

Study of pioglitazone and metformin combination treatment for patients with Metabolic Associated Fatty Liver Disease and prediabetes

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pioglitazone
  • Sponsor:Consorcio Centro De Investigacion Biomedica En Red

Rheumatoid arthritis

Recruiting

Study on Abatacept for Predicting Treatment Response in Patients with Early Rheumatoid Arthritis

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Queen Mary University Of London

Glomerulonephritis minimal lesion+1

Recruiting

Study on Frexalimab, SAR442970, and Rilzabrutinib for Patients Aged 16-75 with Focal Segmental Glomerulosclerosis or Minimal Change Disease

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Chronic lymphocytic leukaemia+1

Recruiting

Study on Zanubrutinib and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Patients

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Obinutuzumab
  • Sponsor:Fundacion PETHEMA

Crohn's disease

Recruiting

Study of Mirikizumab for Children with Moderate to Severe Crohn's Disease

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:0–17 years
  • Substances:Mirikizumab
  • Sponsor:Eli Lilly & Co.

Neovascular age-related macular degeneration

Recruiting

Study on Long-Term Safety of Ranibizumab for Patients with Wet Age-Related Macular Degeneration Using a Port Delivery System

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Ranibizumab
  • Sponsor:F. Hoffmann-La Roche AG

Follicular lymphoma

Recruiting

Study of tazemetostat combined with lenalidomide and rituximab in adult patients with relapsed or refractory follicular lymphoma

Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Lenalidomide
  • Sponsor:Epizyme Inc.

Study on Zanidatamab with Cisplatin and Gemcitabine for Advanced HER2 Positive Biliary Tract Cancer Patients

Recruiting
Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cisplatin
  • Sponsor:Jazz Pharmaceuticals Ireland Limited

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Cordoba

What the registry says about research in the country

01 Oncology Research

Advanced clinical trials focusing on novel treatments for various cancer types, including metastatic colorectal cancer, non-small cell lung cancer, and prostate cancer. Studies evaluate innovative therapeutic approaches and combination treatments.

  • Colorectal Cancer Therapeutics
  • Prostate Cancer Treatments
  • Lung Cancer Interventions

Investigations include targeted therapies and immunotherapy combinations for improved patient outcomes.

02 Immunology Studies

Comprehensive research into autoimmune conditions, including systemic sclerosis, atopic dermatitis, and psoriatic arthritis. Clinical trials evaluate new biological treatments and their effectiveness.

  • Autoimmune Disease Therapies
  • Dermatological Conditions
  • Inflammatory Disorders

Focus on developing targeted treatments for chronic inflammatory conditions.

03 Infectious Disease Prevention

Vaccine development studies targeting cytomegalovirus (CMV) and respiratory syncytial virus (RSV). Research aims to prevent infections in vulnerable populations.

  • Viral Infection Prevention
  • Vaccine Development
  • Immune Response Studies

Emphasis on vaccine efficacy and safety in different age groups.

Back to SpainAll countries
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.